Profile data is unavailable for this security.
About the company
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.
- Revenue in CAD (TTM)0.00
- Net income in CAD-17.32m
- Incorporated2006
- Employees5.00
- LocationBriacell Therapeutics Corp3rd FloorBellevue Centre,, 235-15th StrWEST VANCOUVER V7T 2X1CanadaCAN
- Phone+1 (604) 921-1810
- Fax+1 (604) 921-1898
- Websitehttps://briacell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Decibel Cannabis Company Inc | 109.77m | -1.05m | 28.63m | -- | -- | 0.6673 | 13.69 | 0.2608 | -0.0027 | -0.011 | 0.2567 | 0.1049 | 0.7868 | 1.36 | 8.13 | -- | -0.749 | -3.55 | -1.24 | -5.19 | 38.79 | 38.83 | -0.952 | -7.13 | 0.4277 | 1.58 | 0.5247 | -- | 46.18 | -- | 60.33 | -- | -32.45 | -- |
Medicus Pharma Ltd | 0.00 | -10.48m | 29.06m | -- | -- | -- | -- | -- | -1.41 | -1.41 | 0.00 | -0.0519 | 0.00 | -- | -- | -- | -1,549.38 | -652.37 | -- | -- | -- | -- | -- | -- | -- | -13.22 | -- | -- | -- | -- | -300.86 | -- | -- | -- |
Medipharm Labs Corp | 36.99m | -13.61m | 30.30m | 166.00 | -- | 0.6078 | -- | 0.8192 | -0.0382 | -0.0382 | 0.1017 | 0.1234 | 0.600 | 3.44 | 3.90 | 222,831.30 | -22.07 | -32.88 | -26.27 | -39.56 | 16.37 | -5.88 | -36.78 | -67.66 | 2.20 | -- | 0.0407 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
Thiogenesis Therapeutics Corp | 0.00 | -4.71m | 31.85m | -- | -- | 5.96 | -- | -- | -0.1173 | -0.1173 | 0.00 | 0.1175 | 0.00 | -- | -- | -- | -85.31 | -- | -90.24 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Charlotte's Web Holdings Inc | 80.03m | -41.92m | 34.20m | 164.00 | -- | 0.5335 | -- | 0.4273 | -0.2732 | -0.2732 | 0.5213 | 0.4077 | 0.3668 | 1.07 | 27.08 | 488,002.90 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
Briacell Therapeutics Corp | 0.00 | -17.32m | 34.56m | 5.00 | -- | -- | -- | -- | -1.12 | -1.12 | 0.00 | -0.6938 | 0.00 | -- | -- | -- | -54.70 | -59.37 | -60.36 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
Nurexone Biologic Inc | 0.00 | -5.30m | 37.56m | 8.00 | -- | 7.39 | -- | -- | -0.1132 | -0.1132 | 0.00 | 0.0758 | 0.00 | -- | -- | -- | -124.70 | -213.78 | -146.79 | -596.97 | -- | -- | -- | -- | -- | -- | 0.0066 | -- | -- | -- | 55.45 | -- | -- | -- |
Auxly Cannabis Group Inc | 102.35m | -60.27m | 37.59m | 369.00 | -- | 0.3607 | -- | 0.3673 | -0.0596 | -0.0596 | 0.1017 | 0.0832 | 0.3454 | 2.26 | 5.92 | 277,374.00 | -20.34 | -21.47 | -30.18 | -24.99 | 7.93 | 5.08 | -58.89 | -124.15 | 0.3836 | -1.40 | 0.4399 | -- | 6.99 | 166.85 | 65.84 | -- | -40.92 | -- |
Medexus Pharmaceuticals Inc | 158.95m | 8.08m | 37.91m | 98.00 | 4.24 | 0.9337 | 2.35 | 0.2385 | 0.3659 | 0.3659 | 7.31 | 1.66 | 0.7547 | 2.19 | 5.44 | 1,621,921.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
Immunoprecise Antibodies Ltd | 23.69m | -14.27m | 37.97m | 102.00 | -- | 0.7618 | -- | 1.60 | -0.4121 | -0.4121 | 0.6832 | 1.38 | 0.2939 | 5.25 | 6.76 | 169,018.60 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |